Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fishman

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovaryStephanie A Pangas, Alfred W Rademaker, David A Fishman, et al.
Gynecologic Oncology|September 22, 2009
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasionFeng-qiang Wang, Elaine Barfield, Sonia Dutta, et al.
Gynecologic Oncology|May 28, 2005
LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2)John So, Feng-qiang Wang, Jason Navari, et al.
Gynecologic Oncology|September 8, 2006
S1P regulation of ovarian carcinoma invasivenessYoel Smicun, Scott Reierstad, Feng-Qiang Wang, et al.
Gynecologic Oncology|December 17, 2003
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapyPedro F Escobar, John R Lurain, Diljeet K Singh, et al.
Gynecologic Oncology|July 26, 2011
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)Sonia Dutta, Feng-qiang Wang, Hai-shan Wu, et al.
Proteomics|July 27, 2004
Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnosticsEmanuel F Petricoin, David A Fishman, Thomas P Conrads, et al.
Gynecologic Oncology|March 30, 2004
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physiciansElizabeth A Calhoun, David A Fishman, John R Lurain, et al.
AJR. American Journal of Roentgenology|January 23, 2010
Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubblesArthur C Fleischer, Andrej Lyshchik, Rochelle F Andreotti, et al.
Journal of Oncology|May 24, 2012
Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvementsArthur C Fleischer, Andrej Lyshchik, Makiko Hirari, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovaryStephanie A Pangas, Alfred W Rademaker, David A Fishman, et al.
Gynecologic Oncology|September 22, 2009
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasionFeng-qiang Wang, Elaine Barfield, Sonia Dutta, et al.
Gynecologic Oncology|May 28, 2005
LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2)John So, Feng-qiang Wang, Jason Navari, et al.
Gynecologic Oncology|September 8, 2006
S1P regulation of ovarian carcinoma invasivenessYoel Smicun, Scott Reierstad, Feng-Qiang Wang, et al.
Gynecologic Oncology|December 17, 2003
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapyPedro F Escobar, John R Lurain, Diljeet K Singh, et al.
Gynecologic Oncology|July 26, 2011
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)Sonia Dutta, Feng-qiang Wang, Hai-shan Wu, et al.
Proteomics|July 27, 2004
Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnosticsEmanuel F Petricoin, David A Fishman, Thomas P Conrads, et al.
Gynecologic Oncology|March 30, 2004
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physiciansElizabeth A Calhoun, David A Fishman, John R Lurain, et al.
AJR. American Journal of Roentgenology|January 23, 2010
Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubblesArthur C Fleischer, Andrej Lyshchik, Rochelle F Andreotti, et al.
Journal of Oncology|May 24, 2012
Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvementsArthur C Fleischer, Andrej Lyshchik, Makiko Hirari, et al.
Pageof 6